On the way towards the Sustainable Development Goal (SDG) for health, Europe has one important battle to take on: reducing the proportion of those living with undiagnosed HIV and viral hepatitis. Current status in the EU/EEA: one in seven people living with HIV are unaware of their infection, up to four out of 5 people living with hepatitis B and three out of four people with hepatitis C infection have not yet been diagnosed.
On 30 October, French authorities reported a third autochthonous case of Zika virus (ZIKV) disease in Hyères city, Var department, France. The case had no travel history to Zika-endemic countries.
On 21 October, French authorities reported a second autochthonous case of Zika virus (ZIKV) disease in Hyères city, Var department, France with no travel history to Zika-endemic countries.
This estimate on the “PrEP gap” in Europe was published in a paper in Eurosurveillance stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.
Denmark has reported a travel-related case of malaria caused by Plasmodium cynomolgi in a Danish traveller returning from a visit to forested areas in peninsular Malaysia and Thailand during August-September 2018.
In order to maximise the benefits of treatment for HIV or viral hepatitis, it is critical to test and diagnose people as soon as possible in the course of the infection. ECDC supports this objective of European Testing Week.
The Carnival season will last from 1 to 9 March 2019. In Rio de Janeiro, Brazil, 1 million participants are expected, including many travellers from Europe
The tools to end new HIV infections and AIDS exist. The knowledge on how to use them is agreed upon. Nevertheless late diagnosis of HIV remains a challenges across the European Union and European Economic Area.